Page 2 - Pharmeasy

Primary market revival is still some time away, say analysts

Inflation trajectory and the actions of global central banks, especially the US Fed will be keenly watched by market participants. In this backdrop, primary markets will remain in wait and watch mode

PharmEasy listing pull-out a sign of start-up fatigue: Market experts

Shares of new-age companies have dropped more than 60% amid liquidity squeeze.

PharmEasy calls off its public offer; to go for rights issue instead

API Holdings, the parent company of PharmEasy, wrote to shareholders announcing withdrawal of DRHP

PharmEasy plans $200 million fund raising at lower valuation: Report

Indian drug and medical services startup PharmEasy is in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year's $5.1 billion

Cars24 to Vedantu, start-up lay-offs accelerate on capital crunch worries

Falling valuations, slowing funding rounds add to woes; move aimed at conserving cash and shore up profitability

After 2021 boom, how 2022 could be a year of reckoning for Indian startups

After the boom of 2021, when 44 Indian startups became unicorns, the markets are more selective and investors less enthusiastic in participating at unrealistic valuations

SoftBank-backed Oyo to weigh 50% smaller IPO amid market turmoil: Report

Oyo made preliminary filings in September aiming for an IPO in early 2022

Sebi tightens IPO valuation scrutiny, jolts startups eyeing listing: Report

Sebi probing IPO-bound firms on non-financial metrics, says report; the push comes after Paytm's IPO debacle

PharmEasy parent API Holdings gets Sebi nod for Rs 6,250-cr IPO

API Holdings, the parent company of PharmEasy, Adar Poonawalla-backed Wellness Forever Medicare and metal recycling firm CMR Green Technologies received Sebi's nod for IPOs

Dozen Indian IPOs now under extra investor scrutiny after Paytm debacle

Planned smaller IPOs could have a harder time pricing shares if there is a reduced appetite for new listings

Early mover advantage and scale key themes for PharmEasy investors

Success depends on its ability to integrate various entities across the healthcare value chain

PharmEasy parent files for IPO; looks to garner Rs 6,250 crore

The issue will comprise only primary share sale

Sensex dips 80pts, Nifty holds 18K; Nykaa ends 96% higher over issue price

Debutant Nykaa almost doubled from its issue price of Rs 1,125 at the day's high of Rs 2,248, and finally ended with a 96 per cent premium over its issue price

PharmEasy buys majority stake in healthcare supply chain start-up Aknamed

API's subsidiary PharmEasy, which is planning an IPO, will acquire 975,937 equity share in the company

Digital healthcare firm PharmEasy names 5 independent directors for board

The API board now has 12 members, including five independent directors

India's largest online pharmacy PharmEasy mulls $1 billion IPO: Report

The company, backed by TPG and Temasek Holdings Pte, is working with advisers on a potential offering

PharmEasy parent API Holdings in talks with SoftBank to raise $100-200 mn

Softbank is still evaluating proposal. The firm aims to acquire a company in the healthcare space and to clear loans raised earlier, says source

Thyrocare Technologies dips 7% as PharmaEasy offers to acquire 66% stake

Docon Technologies, along with API Holdings, the parent company of unicorn PharmEasy, also made an open offer for acquisition of additional 26% stake in Thyrocare at a price of Rs 1,300 per share

Top headlines: Steel leads in capacity expansion, GCCs bet on Indian talent

Business Standard brings you the top headlines on Monday

Thyrocare deal: PharmEasy founders out to build Amazon of health care

Of the three healthcare baskets that PharmEasy is targeting, it has already created a significant presence in consultation and treatment